Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib

Volume: 14, Issue: 1, Pages: 325 - 331
Published: Oct 21, 2020
Abstract
Within the class of tyrosine kinase inhibitors (TKIs), which are used for the treatment of numerous advanced cancers, lenvatinib is associated with a higher prevalence of hypertension (HT) compared with other TKIs. In this study, we investigated the effect of lenvatinib on blood pressure (BP) and associated factors.This single-centre, retrospective observational study included 25 consecutive patients treated with lenvatinib for unresectable...
Paper Details
Title
Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib
Published Date
Oct 21, 2020
Journal
Volume
14
Issue
1
Pages
325 - 331
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.